Comprehensive assessment of complete blood count as a prognostic biomarker in interstitial lung diseases
Authors:
- Nimrod UrtregerNUNimrod Urtreger
- Kavitha SelvanKSKavitha Selvan
- Ophir FreundOFOphir Freund
- Tzlil HershkoTHTzlil Hershko
- Inemesit UdofiaIUInemesit Udofia
- Dylan DouglasDDDylan Douglas
- Cathryn T. LeeCLCathryn T. Lee
- Renea JablonskiRJRenea Jablonski
- Mary E. StrekMSMary E. Strek
- Doron Cohn-SchwartzDCDoron Cohn-Schwartz
- Ofir DeriODOfir Deri
- Amir Bar-ShaiABAmir Bar-Shai
Open Access
- 7 August 2026
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 262
Abstract
No abstract availableFunding Information
- National Institutes of Health (NHLBI K23HL146942)
This publication has 30 references indexed in Scilit:
- Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohortsNature Communications, 2023
- Interstitial lung diseasesThe Lancet, 2022
- The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosisRespiratory Medicine, 2020
- Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in miceMolecular Immunology, 2020
- Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesNew England Journal of Medicine, 2019
- Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyThe Lancet Respiratory Medicine, 2019
- Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2018
- Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort studyThe Lancet Respiratory Medicine, 2017
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03European Journal of Cancer, 2009
- Anemia as an independent prognostic factor for survival in patients with cancerCancer, 2002